Roche Acquires Molecular Diagnostics Firm

Though financial details were not disclosed, Roche has declared its acquisition of Ariosa Diagnostics, a California-based molecular diagnostics firm. Ariosa provides highly targeted and non-invasive prenatal testing that assesses the risk of Down syndrome (DS) and other genetic abnormalities.
Source: Medical Design Online News - Category: Medical Equipment Source Type: news